Immunity Program, The Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Front Immunol. 2024 Jun 19;15:1385319. doi: 10.3389/fimmu.2024.1385319. eCollection 2024.
The immune system comprises a complex yet tightly regulated network of cells and molecules that play a critical role in protecting the body from infection and disease. The activity and development of each immune cell is regulated in a myriad of ways including through the cytokine milieu, the availability of key receptors, via tailored intracellular signalling cascades, dedicated transcription factors and even by directly modulating gene accessibility and expression; the latter is more commonly known as epigenetic regulation. In recent years, epigenetic regulators have begun to emerge as key players involved in modulating the immune system. Among these, the lysine methyltransferase DOT1L has gained significant attention for its involvement in orchestrating immune cell formation and function. In this review we provide an overview of the role of DOT1L across the immune system and the implications of this role on health and disease. We begin by elucidating the general mechanisms of DOT1L-mediated histone methylation and its impact on gene expression within immune cells. Subsequently, we provide a detailed and comprehensive overview of recent studies that identify DOT1L as a crucial regulator of immune cell development, differentiation, and activation. Next, we discuss the potential mechanisms of DOT1L-mediated regulation of immune cell function and shed light on how DOT1L might be contributing to immune cell homeostasis and dysfunction. We then provide food for thought by highlighting some of the current obstacles and technical limitations precluding a more in-depth elucidation of DOT1L's role. Finally, we explore the potential therapeutic implications of targeting DOT1L in the context of immune-related diseases and discuss ongoing research efforts to this end. Overall, this review consolidates the current paradigm regarding DOT1L's role across the immune network and emphasises its critical role in governing the healthy immune system and its potential as a novel therapeutic target for immune-related diseases. A deeper understanding of DOT1L's immunomodulatory functions could pave the way for innovative therapeutic approaches which fine-tune the immune response to enhance or restore human health.
免疫系统由一个复杂而又严密调控的细胞和分子网络组成,在保护身体免受感染和疾病方面起着至关重要的作用。每个免疫细胞的活性和发育都受到多种方式的调控,包括细胞因子环境、关键受体的可用性、定制的细胞内信号级联、专门的转录因子,甚至通过直接调节基因的可及性和表达;后者通常被称为表观遗传调控。近年来,表观遗传调节剂已开始成为参与调节免疫系统的关键因素。在这些调节剂中,赖氨酸甲基转移酶 DOT1L 因其参与调节免疫细胞的形成和功能而备受关注。在这篇综述中,我们概述了 DOT1L 在整个免疫系统中的作用及其对健康和疾病的影响。我们首先阐明了 DOT1L 介导的组蛋白甲基化的一般机制及其对免疫细胞中基因表达的影响。随后,我们详细全面地回顾了最近的研究,这些研究确定了 DOT1L 是免疫细胞发育、分化和激活的关键调节剂。接下来,我们讨论了 DOT1L 介导的免疫细胞功能调节的潜在机制,并阐明了 DOT1L 如何有助于免疫细胞的动态平衡和功能障碍。然后,我们通过强调一些当前的障碍和技术限制来引发思考,这些限制阻碍了对 DOT1L 作用的更深入阐述。最后,我们探讨了在免疫相关疾病背景下靶向 DOT1L 的潜在治疗意义,并讨论了为此目的正在进行的研究工作。总的来说,这篇综述整合了当前关于 DOT1L 在免疫网络中的作用的范式,并强调了它在调节健康免疫系统中的关键作用及其作为免疫相关疾病新的治疗靶点的潜力。对 DOT1L 免疫调节功能的更深入了解可能为微调免疫反应以增强或恢复人类健康的创新治疗方法铺平道路。